Cargando…

The Use of Biomaterials in Islet Transplantation

Pancreatic islet transplantation is a therapeutic option to replace destroyed β cells in autoimmune diabetes. Islets are transplanted into the liver via the portal vein; however, inflammation, the required immunosuppression, and lack of vasculature decrease early islet viability and function. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Borg, Danielle J., Bonifacio, Ezio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167046/
https://www.ncbi.nlm.nih.gov/pubmed/21748257
http://dx.doi.org/10.1007/s11892-011-0210-2
_version_ 1782211216781869056
author Borg, Danielle J.
Bonifacio, Ezio
author_facet Borg, Danielle J.
Bonifacio, Ezio
author_sort Borg, Danielle J.
collection PubMed
description Pancreatic islet transplantation is a therapeutic option to replace destroyed β cells in autoimmune diabetes. Islets are transplanted into the liver via the portal vein; however, inflammation, the required immunosuppression, and lack of vasculature decrease early islet viability and function. Therefore, the use of accessory therapy and biomaterials to protect islets and improve islet function has definite therapeutic potential. Here we review the application of niche accessory cells and factors, as well as the use of biomaterials as carriers or capsules, for pancreatic islet transplantation.
format Online
Article
Text
id pubmed-3167046
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-31670462011-09-26 The Use of Biomaterials in Islet Transplantation Borg, Danielle J. Bonifacio, Ezio Curr Diab Rep Article Pancreatic islet transplantation is a therapeutic option to replace destroyed β cells in autoimmune diabetes. Islets are transplanted into the liver via the portal vein; however, inflammation, the required immunosuppression, and lack of vasculature decrease early islet viability and function. Therefore, the use of accessory therapy and biomaterials to protect islets and improve islet function has definite therapeutic potential. Here we review the application of niche accessory cells and factors, as well as the use of biomaterials as carriers or capsules, for pancreatic islet transplantation. Current Science Inc. 2011-07-12 2011 /pmc/articles/PMC3167046/ /pubmed/21748257 http://dx.doi.org/10.1007/s11892-011-0210-2 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Borg, Danielle J.
Bonifacio, Ezio
The Use of Biomaterials in Islet Transplantation
title The Use of Biomaterials in Islet Transplantation
title_full The Use of Biomaterials in Islet Transplantation
title_fullStr The Use of Biomaterials in Islet Transplantation
title_full_unstemmed The Use of Biomaterials in Islet Transplantation
title_short The Use of Biomaterials in Islet Transplantation
title_sort use of biomaterials in islet transplantation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167046/
https://www.ncbi.nlm.nih.gov/pubmed/21748257
http://dx.doi.org/10.1007/s11892-011-0210-2
work_keys_str_mv AT borgdaniellej theuseofbiomaterialsinislettransplantation
AT bonifacioezio theuseofbiomaterialsinislettransplantation
AT borgdaniellej useofbiomaterialsinislettransplantation
AT bonifacioezio useofbiomaterialsinislettransplantation